Established in 1992, by Kenneth and Fiona Acheson, Acheson & Acheson has grown at rapid pace to its position as a distinguished manufacturer for prestige beauty brands, supported by its R&D, manufacturing, regulatory compliance, product design and product development functions. Acheson & Acheson has over 380 employees, including more than 50 people working exclusively on pioneering product development and innovation, keeping its clients at the forefront of the beauty industry.
The business offers an end-to-end service that runs from product/packaging design & development, formulation development, international sourcing, product testing to UK manufacturing, warehouse and distribution. The company also holds numerous high value accreditations, including being a certified BRC Grade A Supplier and compliant with SEDEX.
THG says the investment represents long-term strategic benefits as it reinforces its ambition of “becoming the fully integrated, global digital leader in the beauty and wellbeing sectors.” Future expansion plans include THG’s intention to spend £50m replicating Acheson & Acheson in Europe and USA.
Ameliorate, Acheson & Acheson’s own skincare brand, is included in the purchase and will subsequently be added to THG’s own brand portfolio. Targeted at sufferers of Keratosis Pilaris, the specialist brand is sold globally through leading prestige and specialty retailers including Space NK Apothecary, Selfridges, Boots, Harvey Nichols, Liberty’s and Marks & Spencer.